Clinical trial register · United States · industry-sponsored

Non-Small-Cell Lung Carcinoma NSCLC Trials in the USA

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

9094

Studies in scope

industry-sponsored, all four open statuses

4935

Recruiting now

open to new participants

2188

Lead sponsors

across recruiting studies

Top states

California 3 Arizona 1 Connecticut 1 Florida 1 Georgia 1

Status

Study

Lead sponsor

Phase

Enrol

US states

Start

Active, closed

Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

NCT03003962Non Small Cell Lung Carcinoma NSCLC

AstraZeneca

Phase 3

669

California

2017-01-02

Active, closed

Study of Durvalumab With Tremelimumab Versus SoC as 1st Line Therapy in Metastatic Non Small-Cell Lung Cancer (NSCLC) (NEPTUNE)

NCT02542293Non Small Cell Lung Carcinoma NSCLC

AstraZeneca

Phase 3

953

California, Kentucky, New Jersey, New Mexico, New York, Ohio, Pennsylvania, Texas

2015-11-03

Active, closed

Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC)

NCT02453282Non-Small-Cell Lung Carcinoma NSCLC

AstraZeneca

Phase 3

1,118

Arizona, California, Connecticut, Florida, Georgia, Hawaii, Maryland, Minnesota

2015-07-21

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-usa/condition/non-small-cell-lung-carcinoma-nsclc

Query this register directly

GET /api/trials?country=usa&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.